Performance analysis of Voyager Therapeutics (VYGR)
Annual Return
Over the past 3 years, VYGR has had an average annual return of -30.46%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, VYGR has had an average annual return of -0.99%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, VYGR has had an average annual return of -13.80%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Nov 11, 2015, VYGR has had an average annual return of -14.95%, underperforming the benchmark SPY, which returned +14.61% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -20.10% | -30.68% | -32.83% | +38.35% | +125.08% | -62.09% | -48.75% | +48.40% | -43.37% | +30.31% | -41.83% | +23.38% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.77% | +5.14% | -5.84% | -3.40% | +3.76% | -9.54% | -10.29% | -20.10% | |||||
| 2025 | -3.88% | -25.11% | -17.18% | +5.36% | -23.03% | +13.47% | +2.57% | +5.34% | +38.99% | -0% | -12.43% | -3.91% | -30.68% |
| 2024 | -13.86% | +14.43% | +11.91% | -16.00% | +7.40% | -5.83% | +16.18% | -28.61% | -10.82% | +16.75% | +0.44% | -17.36% | -32.83% |
| 2023 | +54.73% | -23.94% | +7.39% | -5.96% | +57.09% | +0.53% | -18.60% | +7.50% | -22.66% | -15.23% | +10.51% | +16.26% | +38.35% |
| 2022 | +5.50% | +38.86% | +91.91% | -3.80% | -17.34% | -2.46% | +13.36% | -10.91% | -0.83% | -12.50% | +14.67% | +2.72% | +125.08% |
| 2021 | +5.61% | -24.92% | -16.91% | +2.30% | -11.60% | -3.04% | -23.72% | +3.49% | -19.32% | +37.58% | -15.99% | -10.86% | -62.09% |
| 2020 | -20.93% | -1.17% | -16.06% | +18.14% | +11.94% | +4.30% | -12.28% | +6.49% | -9.50% | -0.37% | -21.74% | -14.06% | -48.75% |
| 2019 | +11.59% | +42.99% | +27.59% | +10.24% | +3.37% | +24.81% | -19.14% | -18.81% | -3.69% | -10.58% | -11.36% | +2.26% | +48.40% |
| 2018 | +24.34% | +39.20% | -34.60% | -3.35% | +9.41% | -1.66% | -3.48% | +15.28% | -12.97% | -28.28% | -15.98% | -17.55% | -43.37% |
| 2017 | -6.44% | +8.65% | +2.23% | -21.14% | -15.13% | +1.12% | -8.04% | +17% | +113.59% | +2.28% | -30.54% | +13.47% | +30.31% |
Drawdown analysis of Voyager Therapeutics (VYGR)
The maximum drawdown for the VYGR was -92.11%, occurring on Oct 5, 2021. This drawdown has not yet recovered.
The current VYGR drawdown is -89.97%.
Since Nov 11, 2015 VYGR has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -92.11% | Mar 6, 2018 | 903 | Oct 5, 2021 | Ongoing | Ongoing | Ongoing |
| -72.72% | Dec 7, 2015 | 414 | Jul 31, 2017 | 149 | Mar 5, 2018 | 563 |
| -7.62% | Nov 25, 2015 | 2 | Nov 30, 2015 | 1 | Dec 1, 2015 | 3 |
| -1.66% | Nov 13, 2015 | 1 | Nov 16, 2015 | 1 | Nov 17, 2015 | 2 |
| -1.41% | Nov 11, 2015 | 1 | Nov 12, 2015 | 1 | Nov 13, 2015 | 2 |